Search Results

Your search for Matthew J. Resnick, MD, MPH,Matthew J. Resnick, MD, MPH matches 2 pages

Showing 1 - 2

By Matthew J. Resnick, MD, MPH / May 25, 2015

Prostate Cancer Survivorship: Identifying Opportunities for Improvement

Prostate cancer survivors currently approach 3 million in number and comprise 43% of all male cancer survivors in the United States.1 These men face myriad unique oncologic, functional, emotional, and psychological issues that require evaluation and management throughout the survivorship phase of...

prostate cancer

By Matthew Stenger / May 25, 2015

ASCO Endorses American Cancer Society Prostate Cancer Survivorship Care Guidelines

As reported in the Journal of Clinical Oncology by Matthew J. Resnick, MD, of Vanderbilt University Medical Center, and colleagues, ASCO has endorsed the 2014 American Cancer Society Prostate Cancer Survivorship Care Guidelines.1,2 The ASCO endorsement panel was co-chaired by Dr. Resnick and David...

Dec

Today In Oncology

Search Results

Your search for Matthew J. Resnick, MD, MPH,Matthew J. Resnick, MD, MPH matches 2 pages

Prostate Cancer Survivorship: Identifying Opportunities for Improvement

ASCO Endorses American Cancer Society Prostate Cancer Survivorship Care Guidelines

Evidence-Based Recommendations and Knowledge Gaps Regarding Cardio-Oncology

Pharmacokinetic Comparison of Aumolertinib Osimertinib Gefitinib and Their Major Metabolites in NSCLC

MRD-Guided Chemotherapy Intensification After Induction in Fit Older Patients With AML

Study May Illuminate Cause of Common Checkpoint Inhibitor Adverse Effect

Radiotherapy With Durvalumab or Cetuximab in Locoregionally Advanced Head and Neck Cancer With Contraindication for Cisplatin